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We present two cases of middle-aged women who sustained definite cerebro-vascular infarc-
tions without predisposing risk factors. Work-up did not reveal any underlying etiology. Treat-
ment with antiplatelets and anticoagulants improved the patients’ symptoms. Two and five 
years later, both patients developed pancreatic cancer. In this article, we discuss the association 
between cryptogenic stroke and pancreatic cancer and review the cases described in the litera-
ture with this association. 
 




Stroke is seldomly encountered as the 
first manifestation of cancer. When it oc-
curs, it usually precedes its diagnosis by 
days or months (Peres-Lazaro et al., 2004). 
The cause of stroke in cancer patients is 
usually embolic taking place in the setting 
of a hypercoagulable state. A clear defini-
tion of all the pathogenic mechanisms con-
tributing to stroke in cancer patients has not 
yet been elucidated (Cestari et al.; 2004, 
Adams et al., 1993) 
Case 1: A 45 year-old female, previ-
ously healthy, presented with expressive 
aphasia. Neurologic exam revealed normal 
cranial nerves with no motor or sensory 
deficits. Brain MRI showed an ischemic 
lesion in the left hemisphere. MRA did not 
reveal any thrombotic lesion in the extra- or 
intracranial circulation. Transthoracic echo-
cardiography was normal. Laboratory 
work-up ruled out the presence of diabetes 
mellitus, dyslipidemia, liver or kidney dis-
eases. Hypercoagulability studies including 
ANA, protein C, protein S, anticardiolipin 
antibodies, and factor V Leiden, antithrom-
bin III, MTHFR mutations were negative. 
PT, PTT, and D-dimers were within nor-
mal. The patient was started on antiplatelet 
therapy with consequent clinical improve-
ment. Two years later, the patient presented 
with a painful abdominal mass. CT scan of 
the abdomen revealed a pancreatic lesion 
that turned out to be, on pathologic exami-
nation, an extensive pancreatic anaplastic 
sarcomatoid tumor. The patient died 5 
months later. 
Case 2: A 60 year-old female, known 
healthy, presented with acute severe vertigo 
and headache. Neurologic examination re-
vealed right finger-to-nose dysmetria, 
ataxic gait, and an abnormal Tandem walk-
ing. The patient did not have any motor or 
sensory deficits, cranial nerve dysfunction, 
or neck stiffness. Brain MRI revealed a 
large infarct of the right cerebellar hemi-
sphere and vermis. Transthoracic echocar-
diography was normal. Blood studies were 
normal excluding diabetes, dyslipidemia, 
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renal or liver failure. Hypercoagulable stud-
ies were negative. The patient was started 
on oral anticoagulation with complete reso-
lution of her symptoms. Three years later 
(one year after discontinuation of antico-
agulation), the patient presented with ver-
tigo, horizontal nystagmus, and headache. 
Brain MRI revealed an enlargement of the 
previously present right cerebellar infarct. 
MRA of the intra- and extra-cranial vessels 
showed no evidence of obstructive pathol-
ogy or aneurysmal formation. Trans-
esophageal echocardiography did not reveal 
any cardiac thrombus. Anticoagulation was 
resumed with progressive clinical im-
provement. Two years later, the patient de-
veloped an abdominal pain; CT scan of the 
abdomen revealed a pancreatic mass. Pa-
thology revealed a moderately differenti-
ated pancreatic adenocarcinoma. 
DISCUSSION 
An association between venous throm-
bosis and malignancy (mainly pancreatic 
cancer) was first suggested in 1865 by 
Trousseau (Sack et al., 1977). Arterial 
thrombosis as a paraneoplastic manifesta-
tion is much less common. In a series of 
311 patients with adenocarcinoma of the 
pancreas described by Schattner et al., only 
2 cases developed arterial thromboem-
bolism (Schattner et al., 2002). Cerebral ar-
tery occlusion associated with pancreatic 
neoplasm has been reported in only 4 cases 
(Perez-Lazaro et al., 2004; Schattner et al., 
2002; Medina et al., 2000; Chen et al., 
2004). We are reporting in this article 2 ad-
ditional cases. Cases of cerebral stroke as-
sociated with cancer described in the litera-
ture usually appear in close temporal prox-
imity to the diagnosis of cancer, and might 
be even a preterminal event (Chen et al., 
2004). However, our cases developed 
stroke several years before the diagnosis of 
their pancreatic tumor. Whether this is just 
a coincidental finding or a peculiar, though 
rare, presentation of pancreatic neoplasm 
remains to be elucidated. The pathophysi-
ologic mechanisms of ischemic stroke in 
cancer patients are multiple. The majority 
of cases are embolic as a manifestation of a 
cardioembolic event, a nonbacterial throm-
botic endocarditis (NBTE), an infectious 
endocarditis, or a paradoxical brain embo-
lism in the setting of a right-to-left shunt 
(Sack et al., 1977). Some cases may be sec-
ondary to in situ thrombosis. Autopsy stud-
ies revealed that cerebral infarctions related 
to cancer can be symptomatic or asympto-
matic. Asymptomatic strokes are usually 
secondary to atherosclerosis while symp-
tomatic cerebral infarctions are secondary 
to non-bacterial thromboembolism (Sack et 
al., 1977). The most plausible etiology in 
our two patients based on the clinical pres-
entation and the negative work-up would be 
NBTE. However, a transesophageal echo-
cardiography (TEE) was not done to con-
firm this diagnosis because we did not have 
a suspicion of malignancy. Based on the 
TOAST classification system, our two pa-
tients fall under the category of acute stroke 
of undetermined etiology (Schattner et al., 
2002). In all the reported cases, strokes oc-
curred days to months after the diagnosis of 
cancer. The fact that our patients sustained 
their stroke years before the diagnosis of a 
highly malignant condition defies the the-
ory that the only causes of stroke in cancer 
patients are thrombosis and non-bacterial 
embolism. We speculate that in some can-
cers, possibly only pancreatic, the patho-
logical process starts very early with a so 
far undetermined coagulopathy affecting 
medium or small vessels and undiagnosed 
by the present laboratory panel. We con-
clude from these two cases that patients 
who present with cerebral infarction, with 
neither risk factors for stroke nor associated 
systemic illnesses must be followed up me-
ticulously for an underlying malignancy, 
possibly of pancreatic origin, even several 
years after the diagnosis of the stroke. 
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